Mette Vesterhus

Ass. Professor

University of Bergen

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mette Vesterhus is an Assistant Professor at the University of Bergen in Norway. Her research focuses on liver diseases, particularly primary sclerosing cholangitis and autoimmune hepatitis. Recent publications include studies on RNA sequencing in liver diseases, the impact of biomarkers in cholestatic liver conditions, and the effects of novel therapies on patients. She is actively involved in advancing the understanding of cholestatic episodes and the underlying mechanisms of liver disease.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Annika Bergquist

Karolinska University Hospital

SWEDEN

View details

David Ellinghaus

Professor

Kiel University

GERMANY

View details

Henning Grønbæk

Aarhus University

DENMARK

View details

Charlotte Hedin

Karolinska Institutet

SWEDEN

View details

William Rosenberg

University College London

UNITED KINGDOM

View details

Thomas Damgaard Sandahl

Aarhus University

DENMARK

View details

Kai Markus Schneider

Assistant Professor, Research group leader

RWTH Aachen University

GERMANY

View details

Anne Troldborg

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mette Vesterhus

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis

Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up

Primær skleroserende kolangitt

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis

Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases

Gode TIPS ved alvorlig leversykdom

Fluctuating biomarkers in primary sclerosing cholangitis: a longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease

Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group.

Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems.

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities.

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.

Collaborators (8)

Annika Bergquist

David Ellinghaus

Henning Grønbæk

Charlotte Hedin

William Rosenberg

Thomas Damgaard Sandahl

Kai Markus Schneider

Anne Troldborg

Make your next move.